The final part of the CRESS trilogy - how to evaluate the quality of stability studies.

evaluation preanalytical quality stability

Journal

Clinical chemistry and laboratory medicine
ISSN: 1437-4331
Titre abrégé: Clin Chem Lab Med
Pays: Germany
ID NLM: 9806306

Informations de publication

Date de publication:
16 May 2024
Historique:
received: 26 04 2024
accepted: 26 04 2024
medline: 15 5 2024
pubmed: 15 5 2024
entrez: 15 5 2024
Statut: aheadofprint

Résumé

High quality laboratory results are critical for patient management. However, poor sample quality can impact these results and patient safety. To ensure reliable and accurate results laboratories must be aware of each analyte's stability under various storage conditions and matrices to guarantee correct and dependable outcomes. This knowledge allows laboratories to define the allowable delay between sample collection and centrifugation/analysis for all analytes to guarantee appropriate results quality and interpretation. The EFLM WG-PRE therefore established a 4-step plan to tackle this issue, aiming to standardize and harmonize stability studies for improved comparison and meta-analysis. The plan included the development of checklists and how-to guides for performing and reporting stability studies as well as a central resource of stability data. This manuscript deals with the issue of evaluating publications and incorporating them into a central resource. To evaluate stability studies, the CRESS checklist was used to structure 20 sections used to judge the quality of studies. Each section has 4 levels of quality, with scores converted to numerical values and weighted based on expert opinion. Based on this, a final score ranging from A to D was determined. The procedure was then tested on six manuscripts and checked for agreement between expert judgements. The results demonstrated that the proposed evaluation process is a useful tool to distinguish between best in class manuscripts and those of lower quality. The EFLM WG-PRE strongly believes that the provided recommendations and checklists will help improving stability studies both in quality and standardisation.

Identifiants

pubmed: 38747408
pii: cclm-2024-0527
doi: 10.1515/cclm-2024-0527
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 Walter de Gruyter GmbH, Berlin/Boston.

Références

Hallworth, MJ. The “70% claim”: what is the evidence base? Ann Clin Biochem 2011;48:487–8. https://doi.org/10.1258/acb.2011.011177 .
doi: 10.1258/acb.2011.011177
Plebani, M, Sciacovelli, L, Aita, A. Quality indicators for the total testing process. Clin Lab Med 2017;37:187–205. https://doi.org/10.1016/j.cll.2016.09.015 .
doi: 10.1016/j.cll.2016.09.015
Sciacovelli, L, Padoan, A, Aita, A, Basso, D, Plebani, M. Quality indicators in laboratory medicine: state-of-the-art, quality specifications and future strategies. Clin Chem Lab Med 2023;61:688–95. https://doi.org/10.1515/cclm-2022-1143 .
doi: 10.1515/cclm-2022-1143
Lundberg, GD. Adding outcome as the 10th step in the brain-to-brain laboratory test loop. Am J Clin Pathol 2014;141:767–9. https://doi.org/10.1309/AJCP5KSXWTI2DMCC .
doi: 10.1309/AJCP5KSXWTI2DMCC
ISO 15189:2022 . Medical laboratories – requirements for quality and competence. Available from: https://www.iso.org/standard/76677.html [Accessed 17 May 2020].
Cornes, M, Simundic, AM, Cadamuro, J, Costelloe, SJ, Baird, G, Kristensen, GBB, et al.. The CRESS checklist for reporting stability studies: on behalf of the European federation of clinical chemistry and laboratory medicine (EFLM) working group for the preanalytical phase (WG-PRE). Clin Chem Lab Med 2020;59:59–69. https://doi.org/10.1515/cclm-2020-0061 .
doi: 10.1515/cclm-2020-0061
Gomez-Rioja, R, Von Meyer, A, Cornes, M, Costelloe, S, Vermeersch, P, Simundic, AM, et al.. Recommendation for the design of stability studies on clinical specimens. Clin Chem Lab Med 2023;61:1–11. https://doi.org/10.1515/cclm-2023-0221 .
doi: 10.1515/cclm-2023-0221
BIPM . International vocabulary of metrology (VIM) . Available from: https://www.bipm.org/en/publications/guides/vim.html [Accessed 17 May 2020].
Gómez Rioja, R, Martínez Espartosa, D, Segovia, M, Ibarz, M, Llopis, MA, Bauça, JM, et al.. Laboratory sample stability. Is it possible to define a consensus stability function? An example of five blood magnitudes. Clin Chem Lab Med 2018;56:1806–18. https://doi.org/10.1515/cclm-2017-1189 .
doi: 10.1515/cclm-2017-1189
Cuhadar, S, Atay, A, Koseoglu, M, Dirican, A, Hur, A. Stability studies of common biochemical analytes in serum separator tubes with or without gel barrier subjected to various storage conditions. Biochem Med 2012;22:202–14. https://doi.org/10.11613/bm.2012.023 .
doi: 10.11613/bm.2012.023
Henriksen, LO, Faber, NR, Moller, MF, Nexo, E, Hansen, AB. Stability of 35 biochemical and immunological routine tests after 10 hours storage and transport of human whole blood at 21 °C. Scand J Clin Lab Invest 2014;74:603–10. https://doi.org/10.3109/00365513.2014.928940 .
doi: 10.3109/00365513.2014.928940
Oddoze, C, Lombard, E, Portugal, H. Stability study of 81 analytes in human whole blood, in serum and in plasma. Clin Biochem 2012;45:464–9. https://doi.org/10.1016/j.clinbiochem.2012.01.012 .
doi: 10.1016/j.clinbiochem.2012.01.012
Kift, RL, Byrne, C, Liversidge, R, Babbington, F, Knox, C, Binns, J, et al.. The effect of storage conditions on sample stability in the routine clinical laboratory. Ann Clin Biochem 2015;52:675–9. https://doi.org/10.1177/0004563215580000 .
doi: 10.1177/0004563215580000
Tanner, M, Kent, N, Smith, B, Fletcher, S, Lewer, M. Stability of common biochemical analytes in serum gel tubes subjected to various storage temperatures and times pre-centrifugation. Ann Clin Biochem 2008;45:375–9. https://doi.org/10.1258/acb.2007.007183 .
doi: 10.1258/acb.2007.007183
van Balveren, JA, Huijskens, MJAJ, Gemen, EFA, Péquériaux, NCV, Kusters, R. Effects of time and temperature on 48 routine chemistry, haematology and coagulation analytes in whole blood samples. Ann Clin Biochem 2017;54:448–62. https://doi.org/10.1177/0004563216665868 .
doi: 10.1177/0004563216665868

Auteurs

Michael Cornes (M)

Clinical Chemistry Department, Worcester Acute Hospitals NHS Trust, Worcester, UK.

Pieter Vermeersch (P)

Clinical Department of Laboratory Medicine, 60182 KU Leuven University Hospitals Leuven , Leuven, Belgium.

Ana-Maria Šimundić (AM)

Department of Global Medical & Clinical Affairs, Business Unit for Preanalytics, Greiner Bio-One GmbH, Kremsmünster, Austria.
Faculty of Pharmacy and Medical Biochemistry, Zagreb University, Zagreb, Croatia.

Alexander Von Meyer (A)

Institute for Laboratory Medicine and Microbiology, Munich Municipal Clinic Group, Munich, Germany.

Tomáš Šálek (T)

Institute of Clinical Biochemistry and Diagnostics, Medical Faculty in Hradec Králové, Charles University, Prague, Czechia.
Department of Clinical Biochemistry and Pharmacology, The Tomas Bata Hospital in Zlín, Zlín, Czechia.

Brendan Meyer (B)

BD Life Sciences - Winnersh, Wokingham, UK.

Sean Costelloe (S)

Department of Clinical Biochemistry, 57983 Cork University Hospital Group , Cork, England.

Vincent De Guire (V)

Department of Biochemistry, Maisonneuve-Rosemont Hospital Research Centre, University of Montreal, Montreal, Quebec, Canada.

Ruben Gomez-Rioja (R)

Department of Laboratory Medicine, La Paz-Carlos III-Cantoblanco University Hospital, Madrid, Spain.

Janne Cadamuro (J)

Department of Laboratory Medicine, 31507 Paracelsus Medical University Salzburg , Salzburg, Austria.

Classifications MeSH